Average Co-Inventor Count = 7.13
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vitae Pharmaceuticals, Inc. (24 from 85 patents)
2. Boehringer Ingelheim International Gmbh (9 from 1,535 patents)
3. Vitae Pharmaceuticals, Inc./boehringer-ingelheim (1 from 1 patent)
25 patents:
1. 9163012 - Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
2. 9090605 - Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
3. 9079861 - Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
4. 8933072 - Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
5. 8927539 - Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
6. 8927715 - Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
7. 8883778 - Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
8. 8835426 - Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
9. 8828985 - Carbamate and urea inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10. 8754076 - Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11. 8748444 - Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
12. 8680281 - Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1
13. 8673899 - Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
14. 8598160 - Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
15. 8598163 - Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders